John C. Guatelli

Overview

Best Publications

• A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

  M. N. Oxman;M. N. Oxman;M. J. Levin;G. R. Johnson;K. E. Schmader

  3032
  Citations

• The Interferon-Induced Protein BST-2 Restricts HIV-1 Release and Is Downregulated from the Cell Surface by the Viral Vpu Protein

  Nanette Van Damme;Daniel Goff;Chris Katsura;Rebecca L. Jorgenson

  1257
  Citations

• Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication.

  John C. Guatelli;Kristina M. Whitfield;Deborah Y. Kwoh;Kevin J. Barringer

  1199
  Citations

• Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene.

  M. Y. Chowers;C. A. Spina;T. J. Kwoh;N. J. S. Fitch

  515
  Citations

• The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes.

  C A Spina;T J Kwoh;M Y Chowers;J C Guatelli

  494
  Citations

• Vpu Antagonizes BST-2–Mediated Restriction of HIV-1 Release via β-TrCP and Endo-Lysosomal Trafficking

  Richard S. Mitchell;Chris Katsura;Mark A. Skasko;Katie L Fitzpatrick

  409
  Citations

• Long-term Persistence of Zoster Vaccine Efficacy

  Vicki A Morrison;Gary R Johnson;Kenneth E Schmader;Myron J Levin

  338
  Citations

• Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity

  Heather M. Craig;Mark W. Pandori;John C. Guatelli

  338
  Citations

• Persistence of the Efficacy of Zoster Vaccine in the Shingles Prevention Study and the Short-Term Persistence Substudy

  K. E. Schmader;M. N. Oxman;M. J. Levin;G. Johnson

  291
  Citations

• Human Immunodeficiency Virus Replication and Genotypic Resistance in Blood and Lymph Nodes after a Year of Potent Antiretroviral Therapy

  Huldrych F. Günthard;Joseph K. Wong;Caroline C. Ignacio;John C. Guatelli;John C. Guatelli

  272
  Citations

• Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein.

  M. W. Pandori;N. J. S. Fitch;H. M. Craig;D. D. Richman

  265
  Citations

• Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro.

  C A Spina;J C Guatelli;D D Richman

  253
  Citations

• Fremgangsmåde til forstærkning af et RNA-målsegment

  Gingeras Thomas Raymond;Guatelli John C;Whitfield Kristina Marie

  246
  Citations

• BST-2/tetherin: a new component of the innate immune response to enveloped viruses

  David T. Evans;Ruth Serra-Moreno;Rajendra K. Singh;John C. Guatelli;John C. Guatelli

  231
  Citations

• STIMULATION OF NF-κB ACTIVITY BY THE HIV RESTRICTION FACTOR BST2

  Andrey Tokarev;Marissa Suarez;Wilson Kwan;Kathleen Fitzpatrick

  215
  Citations

• HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment

  Heiko Hauser;Lisa A Lopez;Su Jung Yang;Jill E Oldenburg

  204
  Citations

• THE GROWTH ADVANTAGE CONFERRED BY HIV-1 NEF IS DETERMINED AT THE LEVEL OF VIRAL DNA FORMATION AND IS INDEPENDENT OF CD4 DOWNREGULATION

  Michal Y. Chowers;Mark W. Pandori;Celsa A. Spina;Douglas D. Richman

  199
  Citations

• Tetherin Restricts Productive HIV-1 Cell-to-Cell Transmission

  Nicoletta Casartelli;Marion Sourisseau;Jerome Feldmann;Florence Guivel-Benhassine

  186
  Citations

• Mechanisms for the Inhibition of HIV Replication by Interferons-α, -β, and -γ, in Primary Human Macrophages

  Pascal R.A. Meylan;John C. Guatelli;John C. Guatelli;James R. Munis;James R. Munis;Douglas D. Richman;Douglas D. Richman

  183
  Citations

• Functional landscape of SARS-CoV-2 cellular restriction.

  Laura Martin-Sancho;Mary K. Lewinski;Lars Pache;Charlotte A. Stoneham

  174
  Citations